Industry·June 18, 2026

STATus Report Episode Examines GLP-1 Weight Loss Drug Pipeline

STAT News published a video episode examining the future trajectory of GLP-1 weight loss medications. The segment, hosted by Alex Hogan, explores upcoming developments in the GLP-1 drug class, which includes medications like Ozempic and Wegovy. The episode appears to focus on market trends and pharmaceutical industry developments related to these medications. No specific policy changes, regulatory actions, or Medicaid coverage decisions are reported.

Why it matters for managed care

GLP-1 drugs represent a significant and growing Medicaid pharmacy benefit cost, but this video does not address Medicaid-specific coverage policy, utilization management, or budget impact.

Pharmacy · Managed Care

Read the full article at statnews.com →

Share this briefing